Eli Lilly and Company (LLY) has shown a revenue growth rate of 0.0% year-over-year. Earnings have grown by 0.0% in the same period.
Over the past 4 years, Eli Lilly and Company has delivered a compound annual growth rate (CAGR) of 17.6% for revenue and 40.9% for earnings.
Historical revenue and net income for Eli Lilly and Company
Annual percentage change in revenue and earnings
Historical EPS trends for Eli Lilly and Company
Earnings per share (EPS) is a key metric that shows how much profit Eli Lilly and Company generates for each share of stock. Over the past 4 years, EPS has grown at a CAGR of 41.0%.